Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gianluca, Bazzoli"'
Autor:
Annalisa Bianchera, Esraa’a Alomari, Annalisa Michielon, Gianluca Bazzoli, Nicoletta Ronda, Giovanni Pighini, Ilaria Zanotti, Carmine Giorgio, Andrea Mozzarelli, Ruggero Bettini, Stefano Bruno
Publikováno v:
Pharmaceutics, Vol 14, Iss 12, p 2754 (2022)
Alpha-1 antitrypsin (AAT) deficiency is a genetic disorder associated with pulmonary emphysema and bronchiectasis. Its management currently consists of weekly infusions of plasma-purified human AAT, which poses several issues regarding plasma supplie
Externí odkaz:
https://doaj.org/article/fe13ade3bfd143d499625d3914476803
Autor:
Annalisa Bianchera, Viviana Vilardo, Roberta Giaccari, Annalisa Michielon, Gianluca Bazzoli, Francesca Buttini, Marina Aiello, Alfredo Chetta, Stefano Bruno, Ruggero Bettini
Publikováno v:
Drug Delivery and Translational Research.
The nebulization of alpha-1 antitrypsin (AAT) for its administration to the lung could be an interesting alternative to parenteral infusion for patients suffering from AAT genetic deficiency (AATD). In the case of protein therapeutics, the effect of
Autor:
Luca, Ferrari, Paolo, Martelli, Roberta, Saleri, Elena, De Angelis, Giulia, Ferrarini, Valeria, Cavalli, Benedetta, Passeri, Gianluca, Bazzoli, Giulia, Ogno, Walter, Magliani, Paolo, Borghetti
Publikováno v:
Comparative immunology, microbiology and infectious diseases. 72
This study evaluated the early modulation of the phenotype and cytokine secretion in swine immune cells treated with an engineered killer peptide (KP) based on an anti-idiotypic antibody functionally mimicking a yeast killer toxin. The influence of K
Autor:
Paolo Martelli, Giulia Ferrarini, Gianluca Bazzoli, Valeria Cavalli, Walter Magliani, Giulia Ogno, Luca Ferrari, Roberta Saleri, Paolo Borghetti, Benedetta Passeri, Elena De Angelis
Publikováno v:
Comparative Immunology, Microbiology and Infectious Diseases. 72:101523
This study evaluated the early modulation of the phenotype and cytokine secretion in swine immune cells treated with an engineered killer peptide (KP) based on an anti-idiotypic antibody functionally mimicking a yeast killer toxin. The influence of K